Odysseas Kargiotis - Concepedia

Author

Odysseas Kargiotis

Also Known As

Agnese Novelli, Michela Giustozzi, O Kargiotis, O. Kargiotis, Odysseas Kargiotis, Odysseas Kargiotis, Odysseus Kargiotis, Rao

133

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Metropolitan Hospital National and Kapodistrian University of Athens Democritus University of Thrace University of Tennessee Health Science Center AHEPA University Hospital

About

Odysseas Kargiotis is an author at Metropolitan Hospital specializing in medicine, neurology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	198
2	Public Health	4	4	86
3	Engineering	1	1	18
4	Health Sciences	1	1	29
5	Social Sciences	1	1	23

Odysseas Kargiotis

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader, Neurology	2021	151
Global impact of COVID-19 on stroke care Raul G. Nogueira, Mohamad Abdalkader, Muhammed M. Qureshi, International Journal of Stroke	2021	147
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci, Journal of the American Heart Association	2017	132
RETRACTED ARTICLE: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma Odysseas Kargiotis, Chandramu Chetty, Christopher S. Gondi, Oncogene	2008	127
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes Maurizio Paciaroni, Fabio Bandini, Giancarlo Agnelli, Journal of the American Heart Association	2018	94
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention Maurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, Stroke	2019	91
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study Maurizio Paciaroni, Valeria Caso, Giancarlo Agnelli, Stroke	2022	70
Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries Georgios Tsivgoulis, Odysseas Kargiotis, Andrei V. Alexandrov Expert Review of Neurotherapeutics Cerebrovascular DiseaseIntravenous ThrombolysisThrombosisTranslational MedicineStroke	2017	46
Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic Thanh N. Nguyen, Diogo C Haussen, Muhammad M. Qureshi, Stroke and Vascular Neurology	2021	45
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse Jean‐Christophe Copin, Daniel Jiménez Bengualid, Rafaela da Silva, European Journal of Neuroscience	2011	44

Page 1